KIM HARBIN: Open Payments
NPI 1902947880 · DECATUR, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$320 in 16 payments from 9 companies in 2025. Trend: 2023 $537 · 2024 $365 · 2025 $320
Food & beverage: $320
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 3 | $71 |
| Novo Nordisk Inc | 2 | $48 |
| PFIZER INC. | 2 | $41 |
| ABBVIE INC. | 2 | $35 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $33 |
| Xeris Pharmaceuticals, Inc. | 2 | $30 |
| Indivior Inc. | 1 | $28 |
| Lundbeck LLC | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $15 |
Products named: Korlym, ELIQUIS, XIFAXAN, GVOKE HYPOPEN, SUBLOCADE, Rybelsus, VRAYLAR, Wegovy.
Industry payments across AL — which companies pay providers there.
